[ET Net News Agency, 6 February 2026] INNOCARE (09969) rose 10.2% to HK$13.05.
It hits an intra-day high of HK$13.06, breaking above the 50-D SMA of HK$13.013, and an intra-day low of HK$11.7. The total shares traded was 11.09 million, with a value of HK$138.74m. The active buy/sell ratio is 75:25, with net buying turnover of HK$65.39m. BNP PARIBAS SEC (ASIA) accounts for greatest net responsive buying turnover of HK$966,996, with volume weighted average price of HK$12.278. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$10.68m, with volume weighted average price of HK$12.539. The stock has risen a combined 15.9% over the past 3 consecutive trading days.
Basic Information| Nominal | 13.050 | % Chg | +10.22% |
| High | 13.060 | Low | 11.700 |
| Shares Tr | 11.09m | Turnover | 138.74m |
| 10-D SMA | 11.738 | %H.V | 31.150 |
| 20-D SMA | 12.166 | VWAP | 12.510 |
| 50-D SMA | 13.013 | RSI14 | 60.132 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 75:25, with net buying turnover of HK$65.39m, rising a combined 15.9% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOCARE (09969) | 13.05 | +10.22 |
| GENSCRIPT BIO (01548) | 12.01 | -3.69 |
| INNOVENT BIO (01801) | 79.75 | -0.19 |
| XTALPI (02228) | 11.41 | +1.15 |
| WUXI BIO (02269) | 37.50 | -0.05 |
| WUXI APPTEC (02359) | 114.10 | +0.71 |
| BEONE MEDICINES (06160) | 205.40 | -2.00 |
| DUALITYBIO-B (09606) | 313.60 | -1.51 |
| AKESO (09926) | 101.30 | Unchanged |
| REMEGEN (09995) | 79.50 | -1.79 |
(ed)
Nominal 
